ArticleACS medicinal chemistry letters2017

New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.